Genomic Medicine for Clinicians

The rapid advances in sequencing technologies and genomic medicine are
opening new opportunities and challenges for clinical diagnostics. The
third course in this series aims to equip clinicians from a variety of
fields with the knowledge and skills to work in genomic medicine.

The course programme will provide an introduction to the genetics of
complex diseases. It will also focus on new strategies and technologies
to move from genetic association to understanding causal biology and
disease risk. The use of microbial whole genome sequencing in diagnostic
and public health, particularly its applications to disease outbreak
investigation and antimicrobial prescribing, will also be discussed. The
course will combine lectures, discussions and computer-based sessions.
This year there will be practical sessions on genome-wide association
studies and the use of public genome datasets.

This course is suitable for consultants and trainees (either general
practitioners or other specialists) with an interest in complex disease
genetics, personal genomics and the translation of genomics into clinical
practice. Research-active clinicians are also welcome, but this is not a
requirement. Familiarity with basic genetic concepts  is expected,
but core principles will be reviewed. To facilitate discussions and
interactions with tutors and other participants, places on this course
are limited to 40 participants.

The Royal College of Physicians (London) has awarded this course 15
credits for the purposes of CPD.

Learning outcomes
Following attendance of this course, participants will be able to:

• Describe and critically evaluate the current field of genomic medicine.
• Critique emerging sequencing technologies used in gene identification.
• Interpret and communicate the findings of a Genome-Wide Association Study.
• Integrate and assess the use of genomics in the clinical environment, for example, when prescribing drugs.
• Identify and discuss future opportunities and challenges of the use of genomics in clinical medicine.

The course will start at approximately 9.30 on Wednesday, 25
January and close at approximately 14.00 on
Friday, 27 January 2017.

Topics will include:

• Genomic medicine and complex diseases
• Methods of gene identification: from next-generation sequencing to gene identification
• Interpretation of Genome-Wide Association Studies
• Pharmacogenomics
• Public genomics datasets
• Clinical genomics and disease outbreaks
• Emerging challenges for clinical genetics
• The future of genomic medicine

A draft
programme is available.

Scientific programme committee
Jeffrey Barrett Wellcome Trust Sanger
Institute, UK
Charlie Lees University of Edinburgh, UK

Confirmed tutors
Carl
Anderson Wellcome Trust Sanger
Institute, UK
Ann Daly Newcastle University, UK
Wendy Jones Great Ormond Street Hospital, UK
Luke Jostins University of Oxford, UK
Hilary Martin Wellcome Trust Sanger Institute, UK
Mark McCarthy University of Oxford, UK
Serena Nik-Zainal Wellcome Trust Sanger
Institute, UK
Christine Patch King’s College London, UK
Sharon
Peacock University of Cambridge, UK

Event organiser
Jane Sullivan Wellcome Genome Campus, UK

Fees

The fees include meals and lectures for the duration of the course. The
fee will be requested once acceptance is confirmed.

Accommodation
Participants will stay at The Wellcome Genome Campus Conference Centre,
Hinxton, Cambridge, for the nights of 25 and 26 January 2017.

If you wish to book onsite accommodation either side of the course dates,
please contact the Conference
Centre directly.

Applications
Deadline closed.

Travel visas

Please contact the event organiser if you require a letter to support a
travel visa application. Note that letters will be provided to confirmed
attendees.

Non-European Economic Area or Swiss nationals may be required to have a
visa to enter the UK.
Early application is strongly advised, as this process can take 6-8 weeks
or longer.

Please visit the following websites for further information:
UK Border Agency website and information for general visitors and business
visitors.